ArticlePDF Available

“Life is so easy on ART, once you accept it”: Acceptance, denial and linkage to HIV care in Shiselweni, Swaziland

Authors:

Abstract and Figures

Background: Timely uptake of antiretroviral therapy, adherence and retention in care for people living with HIV (PLHIV) can improve health outcomes and reduce transmission. Médecins Sans Frontières and the Swaziland Ministry of Health provide community-based HIV testing services (HTS) in Shiselweni, Swaziland, with high HTS coverage but sub-optimal linkage to HIV care. This qualitative study examined factors influencing linkage to HIV care for PLHIV diagnosed by community-based HTS. Methods: Participants were sampled purposively, exploring linkage experiences among both genders and different age groups. Interviews were conducted with 28 PLHIV (linked and not linked) and 11 health practitioners. Data were thematically analysed to identify emergent patterns and categories using NVivo 10. Principles of grounded theory were applied, including constant comparison of findings, raising codes to a conceptual level, and inductively generating theory from participant accounts. Results: The process of HIV status acceptance or denial influenced the accounts of patients' health seeking and linkage to care. This process was non-linear and varied temporally, with some experiencing non-acceptance for an extended period of time. Non-acceptance was linked to perceptions of HIV risk, with those not identifying as at risk less likely to expect and therefore be prepared for a positive result. Status disclosure was seen to support linkage, reportedly occurring after the acceptance of HIV status. HIV status acceptance motivated health seeking and tended to be accompanied by a perceived need for, and positive value placed on, HIV health care. Conclusions: The manner in which PLHIV process a positive result can influence their engagement with HIV treatment and care. Thus, there is a need for individually tailored approaches to HTS, including the potential for counselling over multiple sessions if required, supporting status acceptance, and disclosure. This is particularly relevant considering 90-90-90 targets and the need to better support PLHIV to engage with HIV treatment and care following diagnosis.
Content may be subject to copyright.
Life is so easy on ART, once you accept it: Acceptance, denial and
linkage to HIV care in Shiselweni, Swaziland
Shona Horter
a
,
b
,
*
, Zanele Thabede
c
, Velibanti Dlamini
c
, Sarah Bernays
b
,
Beverley Stringer
a
, Sikhathele Mazibuko
d
, Lenhle Dube
d
, Barbara Rusch
e
,
Kiran Jobanputra
a
a
M
edecins Sans Fronti
eres (MSF), London, UK
b
London School of Hygiene and Tropical Medicine, London, UK
c
MSF, Nhlangano, Swaziland
d
Swaziland National AIDS Programme, Ministry of Health of Swaziland, Mbabane, Swaziland
e
MSF, Geneva, Switzerland
article info
Article history:
Received 22 March 2016
Received in revised form
15 December 2016
Accepted 4 January 2017
Available online 6 January 2017
Keywords:
HIV
ART
Qualitative
Linkage
Denial
Acceptance
Diagnosis
abstract
Background: Timely uptake of antiretroviral therapy, adherence and retention in care for people living
with HIV (PLHIV) can improve health outcomes and reduce transmission. M
edecins Sans Fronti
eres and
the Swaziland Ministry of Health provide community-based HIV testing services (HTS) in Shiselweni,
Swaziland, with high HTS coverage but sub-optimal linkage to HIV care. This qualitative study examined
factors inuencing linkage to HIV care for PLHIV diagnosed by community-based HTS.
Methods: Participants were sampled purposively, exploring linkage experiences among both genders
and different age groups. Interviews were conducted with 28 PLHIV (linked and not linked) and 11 health
practitioners. Data were thematically analysed to identify emergent patterns and categories using NVivo
10. Principles of grounded theory were applied, including constant comparison of ndings, raising codes
to a conceptual level, and inductively generating theory from participant accounts.
Results: The process of HIV status acceptance or denial inuenced the accounts of patients' health
seeking and linkage to care. This process was non-linear and varied temporally, with some experiencing
non-acceptance for an extended period of time. Non-acceptance was linked to perceptions of HIV risk,
with those not identifying as at risk less likely to expect and therefore be prepared for a positive result.
Status disclosure was seen to support linkage, reportedly occurring after the acceptance of HIV status.
HIV status acceptance motivated health seeking and tended to be accompanied by a perceived need for,
and positive value placed on, HIV health care.
Conclusions: The manner in which PLHIV process a positive result can inuence their engagement with
HIV treatment and care. Thus, there is a need for individually tailored approaches to HTS, including the
potential for counselling over multiple sessions if required, supporting status acceptance, and disclosure.
This is particularly relevant considering 90-90-90 targets and the need to better support PLHIV to engage
with HIV treatment and care following diagnosis.
©2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Timely uptake of antiretroviral therapy (ART) has a consider-
able effect on individual HIV-related health outcomes and on
reducing the likelihood of HIV transmission (Cohen et al., 2011;
Gardner et al., 2011; INSIGHT START Study Group, 2015; Jenness
et al., 2012; The TEMPRANO ANRS 12136 Study Group, 2015).
The UNAIDS 90-90-90 targets propose that with 90% of people
living with HIV (PLHIV) knowing their status, 90% ART initiation
*Corresponding author. M
edecins Sans Fronti
eres (UK), Lower Ground Floor,
Chancery Exchange, 10 Furnival Street, London EC4A 1AB, UK.
E-mail addresses: shona_horter@yahoo.co.uk (S. Horter), zanethab@gmail.com
(Z. Thabede), msfch-nhlangano-qualitativeresearch@geneva.msf.org (V. Dlamini),
sarah.bernays@lshtm.ac.uk (S. Bernays), beverley.stringer@london.msf.org
(B. Stringer), smazibuko11@gmail.com (S. Mazibuko), lenhlep@yahoo.com
(L. Dube), barbara.rusch@geneva.msf.org (B. Rusch), kiran.jobanputra@london.msf.
org (K. Jobanputra).
Contents lists available at ScienceDirect
Social Science & Medicine
journal homepage: www.elsevier.com/locate/socscimed
http://dx.doi.org/10.1016/j.socscimed.2017.01.006
0277-9536/©2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Social Science & Medicine 176 (2017) 52e59
for those diagnosed and 90% viral suppression for those on ART,
HIV could be eliminated by 2030 (UNAIDS, 2014). Several coun-
tries are now adopting Test and Startapproaches in light of recent
WHO guidelines (World Health Organisation, 2015), whereby
providers offer ART for all individuals diagnosed HIV positive,
irrespective of CD4 count. High coverage and uptake of HIV
testing, linkage to HIV care, treatment initiation, retention in care,
and maintained adherence to ART are required for Test and Start to
reduce HIV incidence successfully (Gardner et al., 2011; Gardner
and Young, 2014; Hayes et al., 2015). However, shortfalls exist at
each of these stages (Gardner et al., 2011; Kilmarx and Mutasa-
Apollo, 2013; Nachega et al., 2014).
Community-based HIV testing services (HTS) can achieve high
uptake, particularly among rst time testers, underrepresented
groups such as men, and those in early stages of disease (Bassett
et al., 2014; Mills and Ford, 2012; Negin et al., 2009; Parker
et al., 2015; Tumwebaze et al., 2012; Tumwesigye et al., 2010;
van Rooyen et al., 2013; Wachira et al., 2012). Yet, reported rates
of linkage to HIV care following diagnosis can be low. Recent
ndings from the ANRS 12249 TasP trial in South Africa demon-
strated just 36.9% linkage to care within three months, among
those tested HIV positive by home-based HTS and not in HIV care
at the time of referral (Plazy et al., 2016), compared to linkage
rates found in Kenya, which were 42% following home-based HTS
(Medley et al., 2013).
Factors that can support or undermine linkage to HIV care have
been documented, including access barriers such as transport
costs and distance to health services (Mills and Ford, 2012), and
the perception that medical care is not required in the absence of
symptoms (Braunstein et al., 2011; Nachega et al., 2014; Rosen and
Fox, 2011). The reasons for patients' clinic non-attendance may be
complex and unintentional, including competing time demands
and anticipated harsh provider attitudes (Ware et al., 2013). Au-
thors argue that how people process an HIV-positive result, their
subsequent actions and their support needs remain insufciently
understood (Gerdts et al., 2014; Mills and Ford, 2012; Wachira
et al., 2012). The need for more research on this topic is increas-
ingly pertinent in light of the move towards Test and Start, with
linkage to care presenting a critical gap that could undermine its
effectiveness in reducing HIV incidence (Iwuji et al., 2016).
Swaziland is one of the rst countries in sub-Saharan Africa to
pilot Test and Start amongst the general population, with a
M
edecins Sans Fronti
eres (MSF) and Swaziland Ministry of Health
(MoH) implementation study in Shiselweni since 2014 and plans
for national adoption imminently.
Swaziland has the highest reported HIV prevalence worldwide
(31% of 18e49 year olds; Swaziland Ministry of Health (2012)). As
part of a MSF/MoH decentralised HIV and TB care project in the
Shiselweni region of southern Swaziland, community-based HTS is
one of the services provided. These HTS approaches were recently
evaluated and found to have achieved high levels of HIV testing
(e.g., 86% uptake reported by a home-based HTS campaign) but
with just 34% of those testing HIV positive then recorded as linked
to pre-ART care at an HIV care facility within six months of the test
date (Parker et al., 2015). Project data suggest that these rates of
linkage to care have improved to around 50% since 2015, following
the implementation of a range of linkage support strategies. These
strategies include individual case management with intensive
counsellor follow-up, point-of-care CD4 count, and a buddying
scheme, which connects newly diagnosed HIV-positive individuals
with a Rural Health Motivator in their community. Yet, it is not
exactly known why linkage to care rates improved (or which
strategies had the greatest effect), and the factors supporting or
hindering individuals' from linking to care following HIV diagnosis
are not well understood. It was therefore pertinent to examine
individuals' experiences with HIV testing and linkage to HIV care
to inform potential adaptation of support strategies to meet
identied needs satisfactorily.
2. Methods
In early 2015, qualitative research was conducted in Swaziland
to examine community member and health practitioner experi-
ences with MSF/MoH-provided community-based HTS in the Shi-
selweni region, in particular exploring factors inuencing linkage to
care for those testing HIV positive. Data were collected through
semi-structured interviews and focus group discussions.
For the purposes of this study, linkage to care refers to atten-
dance at a specied referral facility and registration in the pre-ART
or ART register within six months of the HIV test date as this in-
formation is recorded and available through the project linkage to
care database. The study area was Shiselweni, southern Swaziland,
which includes three health zones: Nhlangano, Hlatikhulu and
Matsanjeni.
Full ethics approval was granted by the Swaziland Scientic and
Ethics Committee and the MSF Ethics Review Board before study
commencement.
2.1. Sampling strategy and participant recruitment
A stratied purposive sampling strategy was adopted to identify
and recruit those able to provide insight into community-based
HTS and linkage to HIV care (Marshall, 1996). The study sample
included three participant groups (Table 1): Patients who tested
HIV positive by community-based HTS interventions (group 1),
including those who had linked to care (group 1a) and those who
had not (group 1b); health practitioners with knowledge and
experience of community-based testing and/or linkage to HIV care
(group 2); and members of the communities where the HTS in-
terventions were delivered (group 3, HIV status unknown).
Group 1 participants were selected from a larger cohort of
patients in the project's community-based testing and linkage
database, including those who had tested HIV positive by
community-based HTS between June and November 2014 and
either linked to care (using the pre-ART or ART enrolment date) or
not (no pre-ART or ART registration recorded) within six months,
to explore their experiences with HIV diagnosis and subsequent
health seeking. The research team selected patients to include a
gender balance and a range of ages, those from each of the three
health zones, and a mix of urban and rural dwellings. A team
member contacted identied participants with information about
the study, requesting their participation. Interviews were arranged
with those who agreed at a time, date and location of their choice,
which was either in the patient's home, a private room within the
health clinic, or a private room within the project ofce.
Group 2 participants were recruited to include health practi-
tioners from the community-based HTS team, clinic-based HTS
staff, expert clients (HIV positive lay counsellors) and nurses
responsible for pre-ART and ART enrolment to explore their views
and experiences working with patients during HIV diagnosis and
linkage to care. Recruitment of this participant group aimed to
give insight into provider perspectives on their rapport with HIV
patients and to understand how their views on the social and
cultural factors inuencing linkage to care may confer or differ
from patient accounts.
Finally, group 3 participants (community members from the
community-based HTS sites) were recruited for focus group dis-
cussions to explore their views on HIV testing and access to HIV
services, providing important contextual information through
insight into shared perspectives and commonly held views.
S. Horter et al. / Social Science & Medicine 176 (2017) 52e59 53
Community members were identied through community-based
expert clients who recruited six to eight members of their com-
munity with unknown HIV status and of the same gender and a
similar age.
2.2. Data generation and analysis
Data were generated through semi-structured interviews with
patients and health practitioners and focus group discussions with
community members in Shiselweni from March to May 2015. In-
terviews with female patients were conducted by a female research
assistant (RA). All interviews with male patients were conducted by
a male RA save one, which was conducted by the female RA, and all
were in siSwati language. The principal investigator (PI; SH) con-
ducted interviews with health practitioners, with most being in
English and two a combination of English and siSwati, with the
assistance of an interpreter. Interviews averaged 50 min. An RA
facilitated focus group discussions in siSwati, with an interpreter
and the PI co-facilitating and taking notes, averaging one hour and
40 min. Interviews and focus group discussions were conducted
according to topic guides following written informed consent. The
consent process included an informed consent form (discussed
verbally), with provisions for condentiality, data storage and
requesting consent for audio recording. All interviews were tran-
scribed verbatim or transcribed and translated equivalently to
maintain meaning and integrity of data.
Data generation and analysis followed an iterative process, with
analysis beginning at the point of data generation and participants
being recruited until evidence of data saturation, when adding
further participants generated no new ndings (Green and
Thorogood, 2009; O'Reilly and Parker, 2013). Data were analysed
thematically using coding to identify emergent patterns, categories,
and concepts from participant accounts. Principles of grounded
theory were drawn upon including constant comparison of codes
within and between cases to raise codes to a conceptual level and
generate theory inductively from participant accounts, and through
actively seeking discrepancies from majority themes (Bradley et al.,
2007; Glaser, 1999; Glaser and Strauss, 1967).
To ensure analytic rigour, interview transcripts were initially
analysed by three researchers independently to identify patterns
and descriptive codes from participant narratives. These patterns
were discussed, results were checked, and an initial coding
framework was developed. Full analysis was conducted by the PI
with NVivo 10 as an analytic aid, with the initial coding framework
being adapted as analysis progressed. Attention was paid to the role
of the researcher in shaping data analysis and interpretation,
emergent themes were tested by examining exceptions and
counter examples, and ndings were triangulated by comparing
participant groups. Finally, a fourth researcher (BS) reviewed the
NVivo project data and coding to enhance validity and minimise
researcher bias.
3. Results
Thirty-nine interviews were conducted, with 28 patients who
tested HIV positive through community-based HTS initiatives and
11 health practitioners (online supplement Tables 2 and 3). Half of
the patients were female and ages ranged from 16 to 69 years.
Among the patients identied for recruitment from the project
patient database, 52% were contactable, and for those who were
non-contactable, there was no telephone number listed on their
testing form, the number listed was incorrect, or they are now
living outside the study area. For the patients who were con-
tactable (n¼31), 100% agreed to be interviewed; of these, 90%
completed the interview, obtaining a nal sample of 28. Three
focus group discussions were conducted with 19 community
members in total.
Of the 28 patients who were interviewed, half of them were
recorded as having linked to HIV care and half as not. It is note-
worthy that during interview 8 of the 14 not linkedparticipants
reported having actually linked to care, either to the clinic they
were referred to or another clinic elsewhere.
Data analysis led to the identication of several key themes as
inuencing individuals' linkage to HIV care: (1) processing an HIV-
positive result and status acceptance and (2) value placed on health
care and the perceived need for HIV care services. Fig. 1 depicts
these themes, as elaborated in this section.
3.1. Processing an HIV-Positive result: shock, doubt and disbelief
Many participants reported experiencing shock after receiving
an HIV-positive test result, feeling distressed, and questioning how
they were infected and the source of HIV infection. Many strug-
gled to accept the diagnosis, with several doubting or disbelieving
the test result.
I was refusing to accept the result when they were telling me
I'm still asking myself how I got infected. P06
I really cried, I felt pain and was shocked that oh my word”’.
P02
When sisi [HTC] told me that I am positive, I just did not believe
it. So I stayed for two years, and some people would come to do
testing, and I would not test because I was like these people tell
lies . P05
Periods of non-acceptance that were described ranged from
months to years and had marked consequences for many in-
dividuals' mental and physical health, seen as a signicant barrier
to accessing care.
It is what can make someone ill, the fact that they do not
accept.C06
Table 1
Characteristics of study sample participants and methods adopted for each.
Participant
group
Participants Data collection method
Group 1 Patients diagnosed HIV positive by community-based HTS Semi-structured interviews (n¼28)
Group 1a
Group 1b
Who are linked to care
Who are not recorded as having linked to care
n¼14
n¼14
Group 2 Health practitioners (with knowledge/experience of HTS
and linkage to care)
Semi-structured interviews (n¼11)
Group 3 General community members (HIV status unknown) Focus group discussions (n¼3, 6e7 participants per group, 19 participants total; 2 with women
aged 17e39 years, 1 with men aged 16e30 years)
S. Horter et al. / Social Science & Medicine 176 (2017) 52e5954
I came back and stayed here at home for almost a year, and I
would go to Nhletjeni and get some pills [not ART], and then it
later got worse and I lay down.C04
Non-acceptance of HIV status was particularly evident among
those who had not felt unwell or were not experiencing symptoms,
which was reiterated by health practitioner participants. Partici-
pants reported confusion over receiving an HIV-positive result and
not identifying themselves as being HIV positive because of their
expectation that HIV infection comes with common symptoms.
If I had got it from him, there would be a difference by now. I
would have gotten sick and bedridden, but I just think that I do
not know.C01
I stayed for the year telling myself that they are lying. It means
that my mind was acting childish because I would tell myself,
how come I am not sick and I do not have any pain. P05
Many participants reported undergoing re-testing for HIV to
conrm whether the result they had received was true. Re-testing
and verifying the HIV-positive result appeared to be an important
step in accessing HIV treatment and care and taking the necessary
steps:
I wanted to see if the test was for real. I wantedto see if what we
did last time was realistic, and I found that it was realistic I
found that I am really HIV positive, and that is when I accepted
that I am really HIV positive and when I started the ART. C08
I was tested, and the result was the same as the one I got before
and then I decided that I should then go to the clinic
because I have heard two different people sharing that infor-
mation with me .P11
Still, this could potentially add to participants' confusion, as one
participant described receiving discordant results on re-testing:
I did not believe that they say now I am positive because yousee
I had tested just that week, and I tested again, I found it positive,
and I tested again the last time and found it negative. It made me
think, what is happening. That is what is making me question.
C06
3.2. Perceptions of HIV risk
Non-acceptance of HIV status was exacerbated by not associ-
ating oneself with HIV through judgements about who gets HIV,
which shaped a sense of personal risk of infection. The reections
individuals made about their perception of risk for HIV included the
described introduction of HIV in Swaziland linked to prostitution;
therefore, those who reported few sexual partners felt they were
not at risk. Perception of HIV risk continues to have associations
with the concepts of morality or social standards despite the
generalised HIV prevalence.
The way in which HIV was rst introduced, that HIV is in those
who go sleeping around, so for those who know that they take
care of themselves, they are far away from thinking of being HIV
positive. HP 02.
I can say I never got to accept it. What came to me was that I
questioned me and HIV? But I am well behaved”’. P05.
Certain men presented as not identifying themselves with risk
of HIV infection, as having multiple partners was seen as a positive
and celebrated achievement for men, which they did not associate
with the negative connotations of promiscuity. Many men
described living a life of Christianity and not believing in sex before
marriage, which could be at odds with the reality of their sexual
practices, thereby creating misalignment of their beliefs, religious
practices, and HIV risk.
I live a life of Christianity. I was very shocked to nd that it is
there when it comes to sex [pause] hmm let me say it is
possible for me to have gotten it through that because it does
not mean that I am this old and I have never, never had sex
without a condom. C13, male
Those who expected that a positive result could be possible and
perceived themselves to be at risk of HIV could accept their status.
This was particularly apparent in the accounts of some of the
women who suspected HIV exposure through their partner's
refusal of condom use or their partner's indelity, which they felt
put them at risk of HIV infection:
I found my boyfriend's treatment, and he had not told me that
he is HIV positive I went to get tested and found that I am HIV
Fig. 1. The process of HIV status acceptance or non-acceptance: inuencing factors and consequences.
S. Horter et al. / Social Science & Medicine 176 (2017) 52e59 55
positive I was expecting it because my boyfriend is HIV
positive. C08, female
3.3. Readiness to test and acceptance
Preparedness for the chance of receiving a positive result and
pre-test information appeared to be vital for acceptance of one's
HIV status. Participants described their feeling of being able to exert
choice in testing as inuencing their preparedness for dealing with
the result and therefore their likelihood of accepting it. Testing
incentives were said to undermine this process, and participants
described instances where individuals' motivation to test was the
incentive (e.g., a t-shirt), rather than to know their health status,
which caused them to go into shock on receiving a positive result.
Testing when you want to test and you wish to test, it is better in
your spirit because you initiated it, so the results will also not be
so hard to accept emotionally.C06
At the tents sometimes, they give incentives. And because as
Swazis, we are hungry, so if there is some incentive, I will not
stay behind, but that is not good because they want to receive
those things but will they accept after that? I do not know. FGD
02eP3
HIV-related counselling and information were seen to be crucial
in providing support and reassurance that there is life after HIV
diagnosis. Some participants reported needing time to process and
come to terms with their result.
I ended up going for counselling and accepting it. What helped
me the most and what I can advise that every person does is to
go for counselling because counselling helps a lot; it soothes the
soul and makes you able to accept the status you have. C08
Individuals' acceptance of their HIV diagnosis and their sense of
hope and belief for living with HIV was emphasised through social
support and encouragement (which was achieved through disclo-
sure). Participants had seen others with HIV surviving, realised that
they were not alone or the minority affected by HIV, and had seen
the transformative effects of ART, compared to the past when many
had seen people around them dying due to HIV-related illnesses.
These experiences enabled individuals to move from questioning
where HIV could have come from to accepting and looking towards
the future.
I accepted my situation because I have seen others surviving
with the virus. C03
I was not scared because there are others I know that are living
with HIV That is what made me not be nervous, as well as
looking at other relatives who have passed on because of it and
not being educated about it.C06
3.4. HIV status disclosure and linkage to care
Non-acceptance was described as a barrier to disclosure of HIV
status as the disbelief, perceived stigma, and fear of negative
judgement may force the HIV-infected individuals to hide their
positive result. Disclosure was seen to help the process of accep-
tance and support engagement in care and receiving treatment. It
enabled access to social support, reassurance, and encouragement,
including for treatment initiation decisions, clinic visits, and
treatment reminders.
I was able to [disclose] after I had accepted I told them that I
am now someone who is like this. If you see me taking pills, do
remind me to take the pills when it is time. C08
I accepted and decided to let them know because I'm going to
need their help and I want them to remind me when it's time to
take the treatment and also when going to the facility.P01
Disclosure could inuence linkage to care, with some partici-
pants who had not accessed care stating that they were waiting to
disclose before going to the health clinic. Participants described
how those who feared inadvertent disclosure of their status would
struggle to take their treatment consistently because they did not
want to be seen taking their treatment. This concern was consid-
ered signicant enough to deter people from even seeking
treatment.
I'm waiting to talk to her rst before I can go to the clinic.C12
Some people die because of not telling their relatives. You nd
that a male person has his friend but is unable to tell them that
they are taking treatment, so he ends up hiding the treatment
they stop taking them because they are scared to tell the lover
that is what kills them. P03
3.5. Perceived need for and value placed on health services
The perceived need for and belief in the benets of health care
were seen to inuence whether individuals would link to care or
not. This was particularly evident where individuals did not feel
unwell, they had not experienced symptoms that they associated
with HIV, and where they did not accept their HIV status. This belief
therefore created the sense that seeking health care was not urgent,
and other life needs, such as work, household activities, and re-
sponsibilities, have higher priority.
I have not gone because I have not even had that cold. I am
someone who is working, and I have not felt that I was sick and I
cannot even work.C01
Some would feel strong, see themselves very good, very healthy,
so they wouldn't see the reason for coming to the clinic.HP01
For some, avoiding potential imminent health deterioration
motivated them to access services even in the absence of symptoms
because of the perceived benets of accessing early care to avoid
reaching a bedridden state.
Going there when you're bit healthy is better than going there
when you're already lying down. This way you can live longer, as
if you don't have this thing. C09
We want life it is better to go to the clinic while you still can
walk there unlike when you're already sick and bedridden. That
is what motivated us'. P08
Avoiding a bedridden statewas not only associated with health
benets including avoiding risk of death, but was also seen in terms
of stigma reduction. Participants felt they would be able to main-
tain good physical health with early access to treatment, thereby
preventing them from developing symptoms and being identiable
as HIV positive.
S. Horter et al. / Social Science & Medicine 176 (2017) 52e5956
I do not want to fall sick and get bedridden and be a written
book for anyone to read.P07
Though ART was described as enabling stigma reduction, some
participants felt reluctant to visit health clinics for fear that doing so
could reveal their HIV status. They feared condentiality breaches
by health practitioners or of being seen queuing for ART-related
services, which could instil feelings of shame. These fears could
be particularly inuential for those who had not fully accepted their
HIV status and who described them as deterring these individuals
from accessing HIV care.
The minute you sit on the bench, you are engulfed with
embarrassment and you feel ashamed, but then you must accept
yourself and not worry yourself about whether you see your
neighbour or anybody. We are all there to get the treatment.P14
Seemingly, socio-cultural norms and expectations relating to
men could create difculties for their accessing health services,
which was mainly described by health practitioner participants
who stated that males are less involved in all aspects of health
services. Furthermore, men were perceived as not wanting to go to
the clinic due to its association as being a woman's place, and the
expectation that men should be strong and not seek health care.
Going to the clinic is something I wouldn't have done except
when I'm being driven there in a wheel barrow. P06 (male)
They are afraid to use hospitals Mainly Swazi men They
don't believe that much in hospitals. They prefer to do some-
thing else.HP04
Counsellor attitudes and the approach taken with linkage
follow-up were important to patients. When patients felt as though
the health practitioner valued their life and wanted them to seek
care for their own well-being, it tapped into their sense of valuing
and prioritising healthcare. On the contrary, more aggressive ap-
proaches when patients felt they were being followed up for the
sole purpose of getting them to go to the clinic could undermine
their motivation and could cause feelings of disappointment and
distrust.
She really followed up on me, and called me and called me to
ask me and said she loved me very much. She stopped once I
went there, and I usually say, aw I thought she loved me but she
stopped calling me. She stopped once I went there. P05
4. Discussion
Our study ndings suggest that HIV status acceptance is
important for a person's engagement with HIV care and access to
social support, quality counselling, knowledge, attitudes, and
practices regarding health care. The process of status acceptance
was inuenced by an individual's awareness that there was a
heightened probability they would receive an HIV-positive result.
Although past studies describe linkage to care and HIV status
denial, as far as we are aware, our study is the rst to portray
acceptance as a longitudinal process in which supporters can
intervene to facilitate individuals' acceptance of an HIV-positive
result.
While the exact way in which someone processes an HIV-
positive result is heterogeneous and individually dened, certain
factors could inuence the transition towards acceptance. These
include the perception of risk for potential HIV infection, including
judgements about HIV; an association of self with images of HIV
positivity; and counsellor support offering reassurance, encour-
agement, and hope for life after diagnosis. Although Swaziland has
the highest reported HIV prevalence rate in the world with a
generalised epidemic, an association of HIV with promiscuityand
prostitutionpersists. Most participants did not identify them-
selves with these behaviours and therefore did not perceive
themselves to be at risk. This non-association with HIV risk led
many to experience shock and disbelief on being diagnosed HIV
positive and made accepting the diagnosis particularly challenging.
Other studies have found non-acceptance of HIV status, often
termed as denial, to negatively affect individuals' access to HIV care,
ART initiation and adherence (Beer et al., 2009; Jenness et al., 2012;
Lindkvist et al., 2015; Manirankunda et al., 2009; Nakigozi et al.,
2013; Nam et al., 2008; Otieno et al., 2010; Stinson and Myer,
2012; Wringe et al., 2009). Reiterating our ndings, doubt and
disbelief on receiving a positive HIV result are associated with a lack
of HIV-related symptoms (Beer et al., 2009; Nakigozi et al., 2013;
Raveis et al., 1998; Wringe et al., 2009), and time can be required
to process, come to terms with, and accept an HIV-positive result
(Gilbert and Walker, 2010; Raveis et al., 1998). In our study, many
reported re-testing for HIV to verify if their result was true, and HIV
testing incentives were seen to undermine status acceptance.
Denial of HIV status has been linked to poor mental and physical
health (Kamen et al., 2012; Moitra et al., 2011). Still, our ndings are
unexpected, given that shock and disbelief can prevail and prevent
PLHIV from accessing HIV care in a setting where HIV knowledge
and familiarity is high and where HIV is perceived to be increas-
ingly normalisedthrough increased access to ART, transforming it
to a chronic manageable condition (Bernays et al., 2015; Russell and
Seeley, 2010).
How individuals respond to chronic diseases, including HIV, are
varied and contextual (Bernays et al., 2015; Harris, 2009). Various
theories can be applied in understanding individuals' reactions to
health and illness, and an HIV diagnosis has been described as a
transition (Russell and Seeley, 2010) and biographical reinforce-
ment (Bernays et al., 2015; Carricaburu and Pierret, 1995; Williams,
2000) through reinforcing components of identity and lifetime
illness experiences or struggles. Yet, because of commonly held
views related to morality and behaviour, an HIV diagnosis in this
context appeared to disrupt the socially set standards and cultural
prescriptions of normality(Bury, 1982), with a reaction of disbelief
and anxiety thus being more common, in line with Bury's (1982)
theory of biographical disruption. The reactions to an HIV-
positive result described in our study echo some of the stages of
grief that Kübler-Ross described by following a patient's diagnosis
with a terminal illness, which include shock, denial, anger, bar-
gaining, depression, and acceptance (Kübler-Ross et al., 1972). As
individuals progressed towards acceptance, elements of transition
appeared, with active adaptation to incorporate illness and its
treatment to daily life, developing approaches for self-management
of HIV and feeling normalagain (Kralik et al., 2004, 2003; Russell
and Seeley, 2010; Telford et al., 2006). We found that acceptance,
disclosure of HIV status, and linkage to HIV care appeared con-
nected. Disclosure enabled support and reassurance, which aided
accessing care and cultivated hope (Gilbert and Walker, 2010;
Nakigozi et al., 2013; Nam et al., 2008).
The perceived need for and value placed on health services
increased individuals' motivation for seeking HIV care. This could
be challenged in the absence of symptoms, where the need for
health care was less evident, a factor that has been reported pre-
viously (Jenness et al., 2012; Nachega et al., 2014; Nakigozi et al.,
2013; Rosen and Fox, 2011). However, some participants
described learning about the benets of early access to treatment
S. Horter et al. / Social Science & Medicine 176 (2017) 52e59 57
and care through receiving HIV information linked to the Test and
Start pilot and through seeing others with HIV experience health
deterioration in the absence of treatment. The avoidance of a
bedridden state, which could render an individual identiable as
HIV positive, had the potential to be a powerful motivator for
accessing care. Yet, fear of health practitioner condentiality
breaches and experiencing stigma on being seen attending a health
clinic for HIV-related care were reported, as found by others (Beer
et al., 2009; Nakigozi et al., 2013; Raveis et al., 1998; Tumwebaze
et al., 2012; Wringe et al., 2009). In our study, this was particu-
larly prevalent among those who had not fully accepted their HIV
status and appeared to be more vulnerable to self-stigma.
4.1. Limitations
During initial patient interviews, it was clear that the inter-
viewer was being associated with the medical programme, which
subsequently improved following adaptations to the study intro-
duction, such as reiterating the non-association of the researchers
with medical teams. Interviews conducted with male patients
recorded as not linked to care were shorter and less in-depth
(including less participant open narrative) than those with fe-
males (average interview length: 30 min for males vs. 55 min for
females, with the exception of one 72-min interview conducted by
a female RA). Interviewer technique is likely to have inuenced the
narratives of these participants, although this could also reect
characteristics of the participant group.
Nearly half of the identied participants for study recruitment
were non-contactable because of a missing or incorrect phone
number captured during HTS. This reects the operational chal-
lenges with linkage follow-up and may have affected the results,
with these participants potentially having different experiences
with testing and linkage to HIV care. In addition, two patients (one
recorded as not linked and one linked) did not attend the agreed
interview appointment, with unknown reasons for non-
participation. However, it appears that the themes that emerged
were robust and reiterated sufciently to evidence data saturation.
Furthermore, the general participation response rate was good.
Although we had requested that focus group discussions be held
with community members who were similar in age, two of the
groups had a large age range. These differences may have inu-
enced the group dynamics, as younger participants were quieter
than older participants, which reects the social interactions that
can be found within wider Swazi society. The generalisability of the
study's ndings is limited to the concepts presented, which also
may not apply in different contexts or settings.
5. Conclusions
This research shows that how individuals process an HIV-
positive result can fundamentally affect their engagement with
health services. Status acceptance enabled access to social support
and increased a sense of need for and value placed on HIV services,
thus inuencing individuals' linkage to HIV care. Although situated
within a generalised high-prevalence epidemic setting, many par-
ticipants in our study did not perceive themselves to be at risk of
HIV and struggled to accept a positive result. Being asymptomatic
could pose particular challenges for accepting an HIV diagnosis and
could create less sense of urgency regarding the need for health
services. Still, there were also perceived benets from accessing
treatment and care early.
Our ndings indicate the need to develop and test linkage
support strategies that address individuals' needs and facilitate
progression to HIV status acceptance. These could include sup-
porting diagnosis preparedness (e.g., through pre-test
information), exploring individuals' perceptions relating to HIV
risk, and expectations for the chance of receiving an HIV-positive
result. Counselling with clear goals is important within pro-
grammes to support status acceptance and disclosure. A exible
approach to patient follow-up should be considered, with varied
intensity and types of support provided depending on the needs of
each individual and with the opportunity for multiple sessions
beyond the point of HIV testing if required. For example, certain
individuals may require more time to process and come to terms
with an HIV diagnosis before engaging in HIV care or initiating ART
than others. HIV prevention programmes should consider our
nding that HIV testing incentives undermined status acceptance
as individuals may be less prepared for a potential positive result.
These ndings are particularly important in light of the move
towards the adoption of Test and Start approaches in many settings,
including in Swaziland. Engaging with how people respond to an
HIV test result is critical to the success of these initiatives, given
how crucial the processes of HIV diagnosis and follow-up are for
patients' access to HIV care. Without addressing specic patient
support needs and improving linkage to HIV care, these approaches
risk being ineffective in reducing HIV incidence and improving the
quality of care to PLHIV.
Acknowledgements
We thank all the patients and staff involved with the MSF/MoH
project in Shiselweni who contributed to this study, with particular
thanks to Dr. Bernhard Kerschberger, Dr. Inoussa Zabsonre and
Thomas A. Obulutsa and to the heads of clinical activities and heads
of community activities (MSF Swaziland). Thanks to Alison Wringe
(LSHTM) for reviewing the drafts and providing technical input,
and to Janet Seeley (LSHTM).
Appendix A Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.socscimed.2017.01.006.
References
Bassett, I.V., Regan, S., Luthuli, P., Mbonambi, H., Bearnot, B., Pendleton, A.,
Robine, M., Mukuvisi, D., Thulare, H., Walensky, R.P., Freedberg, K.A., Losina, E.,
Mhlongo, B., 2014. Linkage to care following community-based mobile HIV
testing compared with clinic-based testing in Umlazi Township, Durban, South
Africa. HIV Med. 15, 367e372. http://dx.doi.org/10.1111/hiv.12115.
Beer, L., Fagan, J.L., Valverde, E., Bertolli, J., 2009. Health-related beliefs and de-
cisions about accessing HIV medical care among HIV-infected persons who are
not receiving care. Aids Patient Care Stds 23, 785e792. http://dx.doi.org/
10.1089/apc.2009.0032.
Bernays, S., Seeley, J., Rhodes, T., Mupambireyi, Z., 2015. What am I livingwith?
growing up with HIV in Uganda and Zimbabwe. Sociol. Health Illn. 37, 270e283.
http://dx.doi.org/10.1111/1467-9566.12189.
Bradley, E.H., Curry, L.A., Devers, K.J., 2007. Qualitative data analysis for health
services research: developing taxonomy, themes, and theory. Health Serv. Res.
42, 1758e1772 . http://dx.doi.org/10.1111/j.1475-6773.2006.00684.x.
Braunstein, S.L., Umulisa, M.-M., Veldhuijzen, N.J., Kestelyn, E., Ingabire, C.M.,
Nyinawabega, J., van de Wijgert, J.H.H.M., Nash, D., 2011. HIV diagnosis, linkage
to HIV care, and HIV risk behaviors among newly diagnosed HIV-positive fe-
male sex workers in Kigali, Rwanda. J. Acquir. Immune Dec. Syndr. 57, e70e76.
http://dx.doi.org/10.1097/QAI.0b013e3182170fd3.
Bury, M., 1982. Chronic illness as biographical disruption. Sociol. Health Illn. 4,
167e182. http://dx.doi.org/10.1111/1467-9566.ep11339939.
Carricaburu, D., Pierret, J., 1995. From biographical disruption to biographical
reinforcement: the case of HIV-positive men. Sociol. Health Illn. 17, 65e88.
http://dx.doi.org/10.1111/1467-9566.ep10934 486.
Cohen, M.S., Chen, Y.Q., McCauley, M., Gamble, T., Hosseinipour, M.C.,
Kumarasamy, N., Hakim, J.G., Kumwenda, J., Grinsztejn, B., Pilotto, J.H.S.,
Godbole, S.V., Mehendale, S., Chariyalertsak, S., Santos, B.R., Mayer, K.H.,
Hoffman, I.F., Eshleman, S.H., Piwowar-Manning, E., Wang, L., Makhema, J.,
Mills, L.A., de Bruyn, G., Sanne, I., Eron, J., Gallant, J., Havlir, D., Swindells, S.,
Ribaudo, H., Elharrar, V., Burns, D., Taha, T.E., Nielsen-Saines, K., Celentano, D.,
Essex, M., Fleming, T.R., 2011. Prevention of HIV-1 infection with early
S. Horter et al. / Social Science & Medicine 176 (2017) 52e5958
antiretroviral therapy. N. Engl. J. Med. 365, 493e505. http://dx.doi.org/10.1056/
NEJMoa1105243.
Gardner, E.M., McLees, M.P., Steiner, J.F., Del Rio, C., Burman, W.J., 2011. The spec-
trum of engagement in HIV care and its relevance to test-and-treat strategies
for prevention of HIV infection. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am.
52, 793e800. http://dx.doi.org/10.1093/cid/ciq243.
Gardner, E.M., Young, B., 2014. The HIV care cascade through time. Lancet Infect.
Dis. 14, 5e6. http://dx.doi.org/10.1016/S1473-3099(13)70272-X.
Gerdts, S.E., Wagenaar, B.H., Micek, M.A., Farquhar, C., Kariaganis, M., Amos, J.,
Gimbel, S., Pfeiffer, J., Gloyd, S., Sherr, K., 2014. Linkage to HIV care and anti-
retroviral therapy by HIV testing service type in Central Mozambique: a
retrospective cohort study. J. Acquir. Immune Dec. Syndr. 1999 (66), e37e44.
http://dx.doi.org/10.1097/QAI.0000000000000081.
Gilbert, L., Walker, L., 2010. My biggest fear was that people would reject me once
they knew my status: stigma as experienced by patients in an HIV/AIDS clinic
in Johannesburg, South Africa. Health Soc. Care Community 18, 139e146. http://
dx.doi.org/10.1111/j.1365-2524.2009.00881.x.
Glaser, B.G., 1999. The future of grounded theory. Qual. Health Res. 9, 836e845.
http://dx.doi.org/10.1177/104973299129122199.
Glaser, B.G., Strauss, A.L., 1967. The Discovery of Grounded Theory: Strategies for
Qualitative Research. Transaction Publishers, Chicago.
Green, J., Thorogood, N., 2009. Qualitative Methods for Health Research. Sage
Publications, London.
Harris, M., 2009. Troubling biographical disruption: narratives of unconcern about
hepatitis C diagnosis. Sociol. Health Illn. 31, 1028e1042. http://dx.doi.org/
10.1111/j.1467-9566.2009.01172.x.
Hayes, R., Fidler, S., Cori, A., Fraser, C., Floyd, S., Ayles, H., Beyers, N., El-Sadr, W.,
HPTN 071 (PopART) Study Team, 2015. HIV Treatment-as-prevention research:
Taking the right road at the crossroads. PLoS Med. 12, e100180 0. http://
dx.doi.org/10.1371/journal.pmed.1001800.
INSIGHT START Study Group, 2015. Initiation of antiretroviral therapy in early
asymptomatic HIV infection. N. Engl. J. Med. http://dx.doi.org/10.1056/
NEJMoa1506816.
Iwuji, C., Orne-Gliemann, J., Balestre, E., Larmarange, J., Thiebaut, R., Tanser, F.,
Okesola, N., Makowa, T., Dreyer, J., Herbst, K., McGrath, N., Barnighausen, T.,
Boyer, S., De Oliveira, T., Rekacewicz, C., Bazin, B., Newell, M.-L., Pillay, D., Dabis,
F., 2016. The impact of universal test and treat on HIV incidence in a rural South
African population: ANRS 12249 TasP trial, 2012-2016. Presented at the 21st
International AIDS Conference, Durban. doi:FRAC0105LB.
Jenness, S.M., Myers, J.E., Neaigus, A., Lulek, J., Navejas, M., Raj-Singh, S., 2012.
Delayed entry into HIV medical care after HIV diagnosis: risk factors and
research methods. Aids Care-Psychol. Socio-Med. Asp. AidsHiv 24, 1240e1248 .
http://dx.doi.org/10.1080/09540121.2012.656569.
Kamen, C., Taniguchi, S., Student, A., Kienitz, E., Giles, K., Khan, C., Lee, S., Gore-
Felton, C., Koopman, C., 2012. The impact of denial on health-related quality of
life in patients with HIV. Qual. Life Res. 21, 1327e1336. http://dx.doi.org/
10.1007/s11136-011-0045-y.
Kilmarx, P.H., Mutasa-Apollo, T., 2013. Patching a leaky pipe: the cascade of HIV
care. Curr. Opin. HIV AIDS 8, 59e64. http://dx.doi.org/10.1097/
COH.0b013e32835b806e.
Kralik, D., Koch, T., Eastwood, S., 2003. The salience of the body: transition in sexual
self-identity for women living with multiple sclerosis. J. Adv. Nurs. 42, 11e20.
http://dx.doi.org/10.1046/j.1365-2648.20 03.02505.x.
Kralik, D., Koch, T., Price, K., Howard, N., 2004. Chronic illness self-management:
taking action to create order. J. Clin. Nurs. 13, 259e267.
Kübler-Ross, E., Wessler, S., Avioli, L.V., 1972. ON death and dying. JAMA 221,
174e179. http://dx.doi.org/10.1001/jama.1972.03200150040010.
Lindkvist, P., Johansson, E., Hylander, I., 2015. Fogging the issue of HIV - barriers for
HIV testing in a migrated population from Ethiopia and Eritrea. Bmc Public
Health 15, 82. http://dx.doi.org/10.1186/s12889-014-1333-6.
Manirankunda, L., Loos, J., Alou, T.A., Colebunders, R., Noestlinger, C., 2009. It's
better not to know: perceived barriers to hiv voluntary counseling and testing
among sub-Saharan African migrants in Belgium. Aids Educ. Prev. 21, 582e593.
Marshall, M.N., 1996. Sampling for qualitative research. Fam. Pract. 13, 522e525.
http://dx.doi.org/10.1093/fampra/13.6.522.
Medley, A., Ackers, M., Amolloh, M., Owuor, P., Muttai, H., Audi, B., Sewe, M.,
Laserson, K., 2013. Early uptake of HIV clinical care after testing HIV-positive
during home-based testing and counseling in Western Kenya. AIDS Behav. 17,
224e234. http://dx.doi.org/10.1007/s10461-012-0344-5.
Mills, E.J., Ford, N., 2012. Home-based HIV counseling and testing as a gateway to
earlier initiation of antiretroviral therapy. Clin. Infect. Dis. 54, 282e284. http://
dx.doi.org/10.1093/cid/cir812.
Moitra, E., Herbert, J.D., Forman, E.M., 2011. Acceptance-based behavior therapy to
promote HIV medication adherence. Aids Care-Psychol. Socio-Med. Asp. Aid-
sHiv 23, 1660e1667. http://dx.doi.org/10.1080/09540121.2011.579945.
Nachega, J.B., Uthman, O.A., del Rio, C., Mugavero, M.J., Rees, H., Mills, E.J., 2014.
Addressing the Achilles' heel in the HIV care continuum for the success of a
test-and-treat strategy to achieve an AIDS-free generation. Clin. Infect. Dis. 59
(Suppl. 1), S21eS27. http://dx.doi.org/10.1093/cid/ciu299.
Nakigozi, G., Atuyambe, L., Kamya, M., Makumbi, F.E., Chang, L.W., Nakyanjo, N.,
Kigozi, G., Nalugoda, F., Kiggundu, V., Serwadda, D., Wawer, M., Gray, R., 2013.
A qualitative study of barriers to enrollment into free HIV care: perspectives of
never-in-care HIV-positive patients and providers in rakai, Uganda. Biomed.
Res. Int. 470245. http://dx.doi.org/10.1155/2013/470245.
Nam, S.L., Fielding, K., Avalos, A., Dickinson, D., Gaolathe, T., Geissler, P.W., 2008. The
relationship of acceptance or denial of HIV-status to antiretroviral adherence
among adult HIV patients in urban Botswana (vol 67, pg 301, 2008). Soc. Sci.
Med. 67, 1934. http://dx.doi.org/10.1016/j.socscimed.20 08.09.023, 1934.
Negin, J., Wariero, J., Mutuo, P., Jan, S., Pronyk, P., 2009. Feasibility, acceptability and
cost of home-based HIV testing in rural Kenya. Trop. Med. Int. Health 14,
849e855. http://dx.doi.org/10.1111/j.1365-3156.2009.02304.x.
O'Reilly, M., Parker, N., 2013. Unsatisfactory Saturation: a critical exploration of
the notion of saturated sample sizes in qualitative research. Qual. Res. 13,
190 e197. http://dx.doi.org/10.1177/1468794112446106.
Otieno, P.A., Kohler, P.K., Bosire, R.K., Brown, E.R., Macharia, S.W., John-Stewart, G.C.,
2010. Determinants of failure to access care in mothers referred to HIV treat-
ment programs in Nairobi, Kenya. Aids Care-Psychol. Socio-Med. Asp. AidsHiv
22, 729e736. http://dx.doi.org/10.1080/09540120903373565.
Parker, L.A., Jobanputra, K., Rusike, L., Mazibuko, S., Okello, V., Kerschberger, B.,
Jouquet, G., Cyr, J., Teck, R., 2015. Feasibility and effectiveness of two
community-based HIV testing models in rural Swaziland. Trop. Med. Int. Health
20, 893e902. http://dx.doi.org/10.1111/tmi.12501.
Plazy, M., Farouki, K.E., Iwuji, C., Okesola, N., Orne-Gliemann, J., Larmarange, J.,
Lert, F., Newell, M.-L., Dabis, F., Dray-Spira, R., 2016. Access to HIV care in the
context of universal test and treat: challenges within the ANRS 12249 TasP
cluster-randomized trial in rural South Africa. J. Int. AIDS Soc. 19 http://
dx.doi.org/10.7448/IAS.19.1.20913.
Raveis, V.H., Siegel, K., Gorey, E., 1998. Factors associated with HIV-infected
women's delay in seeking medical care. Aids Care-Psychol. Socio-Med. Asp.
AidsHiv 10, 549e562.
Rosen, S., Fox, M.P., 2011. Retention in HIV care between testing and treatment in
sub-Saharan Africa: a systematic review. PLoS Med. 8, e1001056. http://
dx.doi.org/10.1371/journal.pmed.1001056.
Russell, S., Seeley, J., 2010. The transition to living with HIV as a chronic condition in
rural Uganda: working to create order and control when on antiretroviral
therapy. Soc. Sci. Med. 70, 375e382. http://dx.doi.org/10.1016/
j.socscimed.2009.10.039.
Stinson, K., Myer, L., 2012. Barriers to initiating antiretroviral therapy during
pregnancy: a qualitative study of women attending services in Cape Town,
South Africa. Ajar-Afr. J. Aids Res. 11, 65e73. http://dx.doi.org/10.2989/
16085906.2012.671263.
Swaziland Ministry of Health, 2012. Swaziland HIV Incidence Measurement Survey
(SHIMS): First Findings Report.
Telford, K., Kralik, D., Koch, T., 2006. Acceptance and denial: implications for people
adapting to chronic illness: literature review. J. Adv. Nurs. 55, 457e464. http://
dx.doi.org/10.1111/j.1365-2648.20 06.03942.x.
The TEMPRANO ANRS 12136 Study Group, 2015. A trial of early antiretrovirals and
isoniazid preventive therapy in Africa. N. Engl. J. Med. 373, 808e822. http://
dx.doi.org/10.1056/NEJMoa1507198.
Tumwebaze, H., Tumwesigye, E., Baeten, J.M., Kurth, A.E., Revall, J., Murnane, P.M.,
Chang, L.W., Celum, C., 2012. Household-based HIV counseling and testing as a
platform for referral to HIV care and medical male circumcision in Uganda: a
pilot evaluation. Plos One 7, e51620. http://dx.doi.org/10.1371/
journal.pone.0051620.
Tumwesigye, E., Wana, G., Kasasa, S., Muganzi, E., Nuwaha, F., 2010. High uptake of
home-based, district-wide, HIV counseling and testing in Uganda. AIDS Patient
Care STDs 24, 735e741. http://dx.doi.org/10.1089/apc.2010.0096.
UNAIDS, 2014. 90e90e90-An Ambitious Treatment Target to Help End the AIDS
Epidemic [WWW Document]. URL. http://www.unaids.org/en/resources/
documents/2014/90-90-90 (accessed 3.10.16).
van Rooyen, H., Barnabas, R.V., Baeten, J.M., Phakathi, Z., Joseph, P., Krows, M.,
Hong, T., Murnane, P.M., Hughes, J., Celum, C., 2013. High HIV testing uptake and
linkage to care in a novel program of home-based HIV counseling and testing
with facilitated referral in KwaZulu-natal, South Africa. Jaids-J. Acquir. Immune
Dec. Syndr. 64, E1eE8.
Wachira, J., Kimaiyo, S., Ndege, S., Mamlin, J., Braitstein, P., 2012. What is the impact
of home-based HIV counseling and testing on the clinical status of newly
enrolled adults in a large HIV care program in western Kenya? Clin. Infect. Dis.
54, 275e281. http://dx.doi.org/10.1093/cid/cir789.
Ware, N.C., Wyatt, M.A., Geng, E.H., Kaaya, S.F., Agbaji, O.O., Muyindike, W.R.,
Chalamilla, G., Agaba, P.A., 2013. Toward an understanding of disengagement
from HIV treatment and care in sub-Saharan Africa: a qualitative study. PLOS
Med. 10, e1001369. http://dx.doi.org/10.1371/journal.pmed.1001369.
Williams, S., 2000. Chronic illness as biographical disruption or biographical
disruption as chronic illness? Reections on a core concept. Sociol. Health Illn.
22, 40e67. http://dx.doi.org/10.1111/1467-9566.00191.
World Health Organisation, 2015. Guideline on when to Start Antiretroviral Therapy
and on Pre-exposure Prophylaxis for HIV [WWW Document]. URL. WHO. http://
www.who.int/hiv/pub/guidelines/earlyrelease-arv/en/ (accessed 10.28.15).
Wringe, A., Roura, M., Urassa, M., Busza, J., Athanas, V., Zaba, B., 2009. Doubts, denial
and divine intervention: understanding delayed attendance and poor retention
rates at a HIV treatment programme in rural Tanzania. Aids Care-Psychol. Socio-
Med. Asp. AidsHiv 21, 632e637. http://dx.doi.org/10.1080/09540120802385629.
S. Horter et al. / Social Science & Medicine 176 (2017) 52e59 59
... Feeling healthy within the context of the test-and-treat policy may influence ART initiation in several ways. First, good health may motivate treatment initiation as a way to maintain health, meet responsibilities and minimise risk of disclosure (Horter et al. 2017). However, good health may also discourage ART initiation because the need for treatment is not evident (Katz et al. 2015;Katz and Bangsberg 2016;Curran et al. 2014;Horter et al. 2017) and due to fear of side effects when otherwise healthy and fear that taking ART may increase the risk of HIV status disclosure (Renju et al. 2017;Dovel 2016). ...
... First, good health may motivate treatment initiation as a way to maintain health, meet responsibilities and minimise risk of disclosure (Horter et al. 2017). However, good health may also discourage ART initiation because the need for treatment is not evident (Katz et al. 2015;Katz and Bangsberg 2016;Curran et al. 2014;Horter et al. 2017) and due to fear of side effects when otherwise healthy and fear that taking ART may increase the risk of HIV status disclosure (Renju et al. 2017;Dovel 2016). To our knowledge, only a few studies have examined these hypotheses under test-and-treat where newly eligible clients are expected to initiate treatment immediately after diagnosis (Pell et al. 2018). ...
... Providers were more likely than clients to identify good health as a barrier to ART. Multiple qualitative studies throughout sub-Saharan Africa have found that feeling healthy at the time of diagnosis discourages early ART initiation (Katz et al. 2015;Mbonye et al. 2016;Horter et al. 2017;Lambert et al. 2018). Quantitative studies confirm these findings, showing that clients with higher CD4 count are significantly less likely to initiate ART than those with low CD4 counts (Siedner et al. 2014;Bor et al. 2016;Rosen and Fox 2011). ...
Article
HIV test-and-treat programmes are being implemented throughout sub-Saharan Africa, enrolling HIV-positive clients into antiretroviral treatment (ART) immediately after diagnosis, regardless of clinical stage or CD4 count. This study conducted in Mozambique examined what influenced clients who tested HIV-positive in the context of test-and-treat to make ART initiation decisions. Eighty in-depth interviews with HIV-positive clients and nine focus group discussions with health care workers were completed across 10 health facilities. 'Good health' acted simultaneously as a barrier and facilitator; clients in good health often found a positive HIV diagnosis hard to cope with since HIV was traditionally associated with ill health. Concerns about ART side effects, fear of inadvertent HIV status disclosure and discrimination, limited privacy at health facilities and long waiting times were also barriers to initiation. In contrast, being in good health also acted as a motivator to start treatment so as to remain healthy, maintain responsibilities such as work and caring for dependents and avoid unwanted disclosure. Study findings offer an in-depth understanding of the complex dynamics between individual perceptions of 'being healthy' and its influence on ART initiation within the context of test-and-treat programme implementation. Keywords: ART; HIV; Mozambique; Treatment uptake; test and-treat.
... A high level of acceptability motivated health seeking and was often accompanied by a perceived need for and positive evaluation of HIV care (Horter et al. 2017). Consistent with previous studies, we found that PLHIV who accepted their HIV-positive status were able to initiate ART earlier compared to patients who denied their HIV-positive status (Nicol et al. 2023). ...
... Some PLHIV were in denial for a long time, and the length of time in denial of an HIV diagnosis varied from person to person (Kiyingi et al. 2023). Shona et al.'s study revealed that denial was related to the perception of HIV risk, and those who did not perceive themselves to be at risk for HIV often had difficulties in accepting an HIV-positive result (Horter et al. 2017). ...
Article
Full-text available
At least 30% of newly diagnosed people living with HIV (PLHIV) have delayed antiretroviral therapy (ART) initiation globally, resulting in irreversible impaired immune function and increased risk of HIV transmission. This study aimed to explore the decision‐making process of ART initiation in China. A phenomenological research design was used and semi‐structured, in‐depth interviews based on dual‐system theory were conducted. Participants were selected using purposive sampling between December 11, 2021 and June 25, 2022. Interpretative phenomenological analysis (IPA) was performed utilizing the software NVivo 12. A total of 34 PLHIV were interviewed. The heuristic system and the analytic system were involved in the complex decision‐making process for ART initiation. Acceptability, negative emotion, and stigma were all parts of the heuristic system. The analytic system included the perception of ART benefits, positive support, and misconception. Two systems interacted with each other in the decision‐making of ART initiation. PLHIV's initiation decision was determined by the components of the dominant system. This theory‐driven qualitative study provided valuable insights on the decision‐making process of ART initiation among newly diagnosed PLHIV.
... This finding is echoed in the literature finding acceptance of HIV as an important factor in ART adherence. 13,26,27 ...
... 30,31 Healthy family relationships enhance disclosure and acceptance, encouraging adherence to ART medication. 26,27,32,33,34,35,36 For this reason, family support is encouraged in the latest ART clinical guidelines. 4 Unfortunately, no clear interventions have been suggested in the South African National ART programme to strengthen family support. ...
Article
Full-text available
Background: South Africa is among the countries with the greatest burden of human immunodeficiency virus (HIV) in the world. The introduction of antiretroviral therapy (ART) has made HIV a manageable chronic health condition with a return to normal life expectancy. Adherence to ART is a prerequisite to realising these benefits.Methods: A qualitative study was conducted using individual semi-structured interviews to understand factors influencing adherence to ART among young adults. The study was conducted at three busy primary care clinics around Mankweng Hospital. Participants aged 18–35 years who had been on ART for more than a year were purposefully selected. Open-ended questions were used to explore factors that influence ART. Recorded interviews were transcribed verbatim and translated. The coded transcripts were thematically analysed.Results: Eight major themes were identified to influence ART adherence among young adults: medication-related factors, healthcare system factors, attitudes of healthcare workers, economic factors, disclosure, acceptance, mobile phone reminders and family support.Conclusion: Adherence to ART is a major problem in our communities, and people living with HIV are still finding it challenging to optimally adhere to their ART medication because of the identified factors that influence ART adherence. Family support is a significant factor that was identified to positively influence ART as it leads to disclosure and acceptance of HIV-positive status, better emotional well-being and subsequently improved ART adherence.Contribution: This study underscores the importance of a family-oriented, patient-centred care approach in managing HIV and ART adherence.
... The African Union Commission [59] has demonstrated that high rates of child marriage often coincide with high rates of HIV infection in many countries. Acceptance of HIV status is critical for the effectiveness of HIV tests and related activities, whereas self-denial following a positive diagnosis can hinder adherence [60]. ...
Article
Background In many parts of the world, men who have sex with men and transgender individuals face criminalization and discrimination. As a result, they are less likely to seek medical help, despite experiencing higher rates of HIV/AIDS, mental health issues, and other health problems. Reaching key populations (KPs) with essential testing, care, and treatment services can be challenging, as they often have a higher likelihood of contracting and spreading the virus. They have limited access to antiretroviral (ARV) therapy (ART) services, which means that KPs may continue to serve as reservoirs for new HIV infections if they do not receive effective HIV programming. This ongoing issue complicates efforts to control the epidemic. Therefore, modeling a digital health system to track ARV medication access and use is crucial. This paper advocates for the use of digital interventions to manage the health of KPs in underserved regions, using Nigeria as a case study. Objective This study aims to assess digital health interventions for monitoring medication and consultations among transgender people in underserved communities. It also sought to determine whether a system exists that could support ART adherence in Nigeria. Additionally, the study evaluated design strategies to address privacy and confidentiality concerns, aiming to reduce nonadherence to ARV medications among KPs in Nigeria. Methods A qualitative approach was adopted for this research, involving a thematic analysis of information collected from interviews with clinicians and other health practitioners who work directly with these communities, as well as from an interactive (virtual) workshop. Results The findings from the thematic analysis indicate a need to increase attendance at ART therapy sessions through the implementation of an intensive care web app. Unlike previous solutions, this study highlights the importance of incorporating a reminder feature that integrates with an in-app telemedicine consultancy platform. This platform would facilitate discussions about client challenges, such as adverse drug effects, counseling sessions with clinical psychologists, and the impact of identity discrimination on mental health. Other data-driven health needs identified in the study are unique drug request nodes, client-led viral load calculators, remote requests, and drug delivery features within the web app. Participants also emphasized the importance of monitoring medication compliance and incorporating user feedback mechanisms, such as ratings and encouragement symbols (eg, stars, checkmarks), to motivate adherence. Conclusions The study concludes that technology-driven solutions could enhance ART adherence and reduce HIV transmission among transgender people. It also recommends that local governments and international organizations collaborate and invest in health management services that prioritize health needs over identity.
... Stigma has an over-arching barrier, on rationalities regarding treatment and HIV status which is also exacerbated negative community religious perceptions (9-11). Horter et al, (2017) concluded that the process of HIV status acceptance or denial is greatly influenced by the accounts of patients' health seeking and linkage to care (12). However, PLHV have concerns about segregated HIV clinical services (9). ...
Article
Full-text available
Effective HIV prevention programs require a combination of behavioral, biomedical and structural interventions. Behavior interventions address the cultural contexts within which risk behaviors occur and aim to stimulate uptake of HIV prevention services. This research seeks to understand the relationship between the underlying needs people living with HIV (PLHIV) have from treatment, their personality traits, and how it influences treatment behavior. The overall focus is to develop the most successful campaign across sub-Saharan Africa, but primarily in Malawi and Zimbabwe. This was a cross-sectional quantitative study where interviews with 786 adult PLHIV and 504 healthcare workers (HCWs) were conducted via Computer Assisted Telephone Interviewing (CATI) in Malawi and Zimbabwe. PLHIV in Malawi and Zimbabwe are typically adherent to their medication. For PLHIV the power of the pill is scary and controlling but also liberating. Early associations with HIV tend to derive from negative comments being made about PLHIV, which fosters a sense that PLHIV are not accepted by the wider community. HCWs in Malawi and Zimbabwe do prioritize emotional support but have limited capacity to provide wider pastoral care. PLHIV, and HCWs, have good awareness of what viral suppression is, but do not always understand what it truly means. Utilization of communication channels that are acceptable and trusted will be key to successful HIV literacy treatment campaigns.
... For HIV-positive individuals, self-forgiveness can lessen self-stigma, reduce feelings of shame and isolation (Zulkarnain et al., 2020), and foster acceptance of their health condition. This acceptance promotes adherence to healthcare routines, including antiretroviral therapy (ART) and other prescribed treatments, resulting in improved health management (Foster et al., 2020;Horter et al., 2017). Additionally, self-forgiveness is linked to enhanced mental health outcomes, notably reducing symptoms of depression and anxiety prevalent among those living with HIV (Ayano et al., 2020(Ayano et al., , 2021Martin et al., 2012). ...
Article
Full-text available
Guided by the bio-psycho-socio-spiritual approach, this randomized controlled trial assessed the efficacy of a self-forgiveness intervention among 60 HIV-positive individuals in Poland. Participants underwent a 90-min "Restore: The Journey Toward Self-Forgiveness" session, in contrast to a wait-list control group. The intervention significantly enhanced self-forgiveness, spirituality, mental well-being, and heart rate variability in response to a cognitive stressor (i.e., a mental arithmetic challenge). Significant effects were observed in both between-group and within-subject comparisons. These results support the incorporation of self-forgiveness into psychological rehabilitation programs for HIV to improve quality of life and health outcomes.
... Self-acceptance of HIV status has a positive impact on PLHIV (Nasir et al., 2023). Accepting HIV status encourages a person to seek health care and is often accompanied by a sense of need and value for HIV medical care (Horter et al., 2017). Eliminating stigma and discrimination must also be done so that PLHIV is more accepted by families and communities (Dahlui et al., 2015) because living a carefree life in an environment that is willing to accept them is the expectation of PLHIV (Nasir et al., 2023). ...
Article
Full-text available
The cause of death of people with HIV/AIDS (ODHA) is not only caused by immunodeficiency factors but also caused by the influence of stigma or social discrimination received, resulting in psychosocial disorders on motivation and quality of life. This study aims to determine the perspective of PLHIV on psychosocial disorders due to discrimination and stigma received and its impact. This research is a qualitative research with a field research design. Data collection using Focus Group Discussion and in-depth interviews involving 18 informants at Yayasan Pelangi Maluku. The impact of psychosocial disorders is experienced as a decrease in the quality and motivation of life. Decreased quality of life was reported by informants, including poor social relationships, problems accepting HIV status, and anger of PLHIV towards themselves. The decrease in motivation to live with PLHIV is reflected in the unwillingness to seek treatment, suicidal ideation, and the desire to transmit HIV. This study showed the existence of psychosocial disorders with a large impact on the motivation and quality of life of PLHIV. This shows the importance of psychosocial assistance to PLHIV through continuous education for families and communities to reduce stigma and discrimination and its impact on PLHIV.
Article
Full-text available
Background The human immunodeficiency virus and acquired immunodeficiency syndrome (HIV and AIDS) pandemic has greatly affected Africa, particularly Ghana. The pandemic remains a public health concern, particularly in terms of accessing essential medication and improving quality of life for people living with the disease. Objectives This study aimed to explore and describe the experiences of persons diagnosed and living with HIV who are on antiretroviral therapy. Method A qualitative, exploratory, descriptive, and contextual design was used. The research population included persons diagnosed with HIV who were receiving antiretroviral therapy at three public hospitals in Ghana. Data saturation was achieved after conducting 15 semi-structured interviews. Creswell’s six steps of data analysis were used to analyse the data, which resulted in the emergence of one main theme and six sub-themes. Results The main theme identified by the researchers highlighted the participants’ diverse experiences of being diagnosed and living with HIV. It was found that the study participants expressed shock, disbelief, surprise, and fear of death after being diagnosed with HIV. The participants also experienced stigmatisation, discrimination, and rejection. Conclusion There is a need for further research on the extent of discrimination and stigmatisation and the effect on optimal adherence to antiretroviral therapy. Continuous public education on HIV is required to limit the extent of discrimination and stigmatisation. Contribution The study has highlighted the various emotions related to stigma and discrimination expressed by persons living with HIV (PLHIV). The findings will guide policy on eliminating discrimination and stigmatisation for people living with HIV.
Article
The purpose of this phenomenological study is to explore the acceptance of HIV diagnosis of women in stable relationships. Based on eight semistructured interviews with cisgender Portuguese women, thematic analysis identified four interrelated themes that illustrated the emotional and psychosocial dynamics involved in this journey. Following an HIV diagnosis, participants grappled with complex emotions, societal perceptions, and the internalization of stigma. Marital relationships underwent profound changes, with trust breakdown and emotional distancing. Coping mechanisms ranged from seeking support to living in secrecy, which impacted psychological well-being. Acceptance of HIV diagnosis is influenced by self-stigmatization, societal perceptions of HIV, and gender dynamics. The findings contribute to the development of tailored interventions, emphasizing the interconnected nature of physical and psychological well-being in the diagnosis acceptance process.
Article
Full-text available
Objective The aim of the research was to understand what drives and motivates young women living with HIV in their treatment journeys, as well as their key influencers. The findings will assist in appreciating their obstacles to treatment and constructing the most effective ways to convey fresh messages to them. These insights will contribute to the messaging developed for a campaign across sub-Saharan Africa, primarily Malawi and Zimbabwe. Design This was a qualitative study conducted in order to build an understanding of unknown parts of the HIV treatment journey through in-depth interviews. A hybrid approach was used to conduct thematic analysis. Setting and participants Study participants were HIV-positive women, their influencers (eg, parents/partners/siblings/aunts and uncles/religious leaders, etc) and healthcare providers from a range of regions in Zimbabwe and Malawi. Results A total of 26 young people living with HIV (PLHIV), 29 healthcare providers and 24 influencers such as maternal figures in the community were interviewed. Two main broad insights were drawn, that is, key needs and wider contextual factors. The key needs of young PLHIV to stay on treatment were empathy, support and emotional connection with antiretroviral therapy (ART), while the wider contextual factors impacting their treatment journeys were structural challenges and cultural reference points. Fear of shame and humiliation can also be significant barriers to disclosure and treatment. The fear predisposes the PLHIV to the need for empathy, support and connection with ART. Mental health and anxiety appear to be comorbid with HIV. Some PLHIV have a small and limited support network leading to very few people living openly with HIV. There is no ‘one-size-fits-all’ approach, and maximising campaign reach will likely need a multifaceted approach. Conclusion Currently, the relationship between nurses and PLHIV can appear to be transactional. Through learning about the community (including PLHIV), there are more chances of communicating in a way that resonates.
Article
Full-text available
Introduction: We aimed to quantify and identify associated factors of linkage to HIV care following home-based HIV counselling and testing (HBHCT) in the ongoing ANRS 12249 treatment-as-prevention (TasP) cluster-randomized trial in rural KwaZulu-Natal, South Africa. Methods: Individuals ≥16 years were offered HBHCT; those who were identified HIV positive were referred to cluster-based TasP clinics and offered antiretroviral treatment (ART) immediately (five clusters) or according to national guidelines (five clusters). HIV care was also available in the local Department of Health (DoH) clinics. Linkage to HIV care was defined as TasP or DoH clinic attendance within three months of referral among adults not in HIV care at referral. Associated factors were identified using multivariable logistic regression adjusted for trial arm. Results: Overall, 1323 HIV-positive adults (72.9% women) not in HIV care at referral were included, of whom 36.9% (n=488) linked to care <3 months of referral (similar by sex). In adjusted analyses (n=1222), individuals who had never been in HIV care before referral were significantly less likely to link to care than those who had previously been in care (<33% vs. >42%, p<0.001). Linkage to care was lower in students (adjusted odds-ratio [aOR]=0.47; 95% confidence interval [CI] 0.24-0.92) than in employed adults, in adults who completed secondary school (aOR=0.68; CI 0.49-0.96) or at least some secondary school (aOR=0.59; CI 0.41-0.84) versus ≤ primary school, in those who lived at 1 to 2 km (aOR=0.58; CI 0.44-0.78) or 2-5 km from the nearest TasP clinic (aOR=0.57; CI 0.41-0.77) versus <1 km, and in those who were referred to clinic after ≥2 contacts (aOR=0.75; CI 0.58-0.97) versus those referred at the first contact. Linkage to care was higher in adults who reported knowing an HIV-positive family member (aOR=1.45; CI 1.12-1.86) versus not, and in those who said that they would take ART as soon as possible if they were diagnosed HIV positive (aOR=2.16; CI 1.13-4.10) versus not. Conclusions: Fewer than 40% of HIV-positive adults not in care at referral were linked to HIV care within three months of HBHCT in the TasP trial. Achieving universal test and treat coverage will require innovative interventions to support linkage to HIV care.
Article
Full-text available
Background: In sub-Saharan Africa, the burden of human immunodeficiency virus (HIV)-associated tuberculosis is high. We conducted a trial with a 2-by-2 factorial design to assess the benefits of early antiretroviral therapy (ART), 6-month isoniazid preventive therapy (IPT), or both among HIV-infected adults with high CD4+ cell counts in Ivory Coast. Methods: We included participants who had HIV type 1 infection and a CD4+ count of less than 800 cells per cubic millimeter and who met no criteria for starting ART according to World Health Organization (WHO) guidelines. Participants were randomly assigned to one of four treatment groups: deferred ART (ART initiation according to WHO criteria), deferred ART plus IPT, early ART (immediate ART initiation), or early ART plus IPT. The primary end point was a composite of diseases included in the case definition of the acquired immunodeficiency syndrome (AIDS), non-AIDS-defining cancer, non-AIDS-defining invasive bacterial disease, or death from any cause at 30 months. We used Cox proportional models to compare outcomes between the deferred-ART and early-ART strategies and between the IPT and no-IPT strategies. Results: A total of 2056 patients (41% with a baseline CD4+ count of ≥500 cells per cubic millimeter) were followed for 4757 patient-years. A total of 204 primary end-point events were observed (3.8 events per 100 person-years; 95% confidence interval [CI], 3.3 to 4.4), including 68 in patients with a baseline CD4+ count of at least 500 cells per cubic millimeter (3.2 events per 100 person-years; 95% CI, 2.4 to 4.0). Tuberculosis and invasive bacterial diseases accounted for 42% and 27% of primary end-point events, respectively. The risk of death or severe HIV-related illness was lower with early ART than with deferred ART (adjusted hazard ratio, 0.56; 95% CI, 0.41 to 0.76; adjusted hazard ratio among patients with a baseline CD4+ count of ≥500 cells per cubic millimeter, 0.56; 95% CI, 0.33 to 0.94) and lower with IPT than with no IPT (adjusted hazard ratio, 0.65; 95% CI, 0.48 to 0.88; adjusted hazard ratio among patients with a baseline CD4+ count of ≥500 cells per cubic millimeter, 0.61; 95% CI, 0.36 to 1.01). The 30-month probability of grade 3 or 4 adverse events did not differ significantly among the strategies. Conclusions: In this African country, immediate ART and 6 months of IPT independently led to lower rates of severe illness than did deferred ART and no IPT, both overall and among patients with CD4+ counts of at least 500 cells per cubic millimeter. (Funded by the French National Agency for Research on AIDS and Viral Hepatitis; TEMPRANO ANRS 12136 ClinicalTrials.gov number, NCT00495651.).
Article
Full-text available
Background: Data from randomized trials are lacking on the benefits and risks of initiating antiretroviral therapy in patients with asymptomatic human immunodeficiency virus (HIV) infection who have a CD4+ count of more than 350 cells per cubic millimeter. Methods: We randomly assigned HIV-positive adults who had a CD4+ count of more than 500 cells per cubic millimeter to start antiretroviral therapy immediately (immediate-initiation group) or to defer it until the CD4+ count decreased to 350 cells per cubic millimeter or until the development of the acquired immunodeficiency syndrome (AIDS) or another condition that dictated the use of antiretroviral therapy (deferred-initiation group). The primary composite end point was any serious AIDS-related event, serious non-AIDS-related event, or death from any cause. Results: A total of 4685 patients were followed for a mean of 3.0 years. At study entry, the median HIV viral load was 12,759 copies per milliliter, and the median CD4+ count was 651 cells per cubic millimeter. On May 15, 2015, on the basis of an interim analysis, the data and safety monitoring board determined that the study question had been answered and recommended that patients in the deferred-initiation group be offered antiretroviral therapy. The primary end point occurred in 42 patients in the immediate-initiation group (1.8%; 0.60 events per 100 person-years), as compared with 96 patients in the deferred-initiation group (4.1%; 1.38 events per 100 person-years), for a hazard ratio of 0.43 (95% confidence interval [CI], 0.30 to 0.62; P<0.001). Hazard ratios for serious AIDS-related and serious non-AIDS-related events were 0.28 (95% CI, 0.15 to 0.50; P<0.001) and 0.61 (95% CI, 0.38 to 0.97; P=0.04), respectively. More than two thirds of the primary end points (68%) occurred in patients with a CD4+ count of more than 500 cells per cubic millimeter. The risks of a grade 4 event were similar in the two groups, as were the risks of unscheduled hospital admissions. Conclusions: The initiation of antiretroviral therapy in HIV-positive adults with a CD4+ count of more than 500 cells per cubic millimeter provided net benefits over starting such therapy in patients after the CD4+ count had declined to 350 cells per cubic millimeter. (Funded by the National Institute of Allergy and Infectious Diseases and others; START ClinicalTrials.gov number, NCT00867048.).
Article
Full-text available
Reflecting on a Policy Forum article by Till Bärnighausen and colleagues, the HPTN 071 (PopART) Study Team consider ethical and study power concerns and the importance of the trial's future findings.
Article
Full-text available
To evaluate the feasibility (population reached, costs) and effectiveness (positivity rates, linkage to care) of two strategies of community-based HIV testing and counselling (HTC) in rural Swaziland. Strategies used were mobile-HTC (MHTC) and home-based-HTC (HBHTC). Information on age, sex, previous testing and HIV results was obtained from routine HTC records. A consecutive series of individuals testing HIV-positive were followed-up for 6 months from the test date in order to assess linkage to care. 9,060 people were tested: 2,034 through MHTC and 7,026 through HBHTC. A higher proportion of children and adolescents (<20 years) were tested through HBHTC than MHTC (57% vs. 17%; p<0.001). MHTC reached a higher proportion of adult men than HBHTC (42% vs. 39%; p=0.015). Of 398 HIV-positive individuals, only 135 (34%) were enrolled in HIV care within 6 months. Of 42 individuals eligible for Antiretroviral Therapy, 22 (52%) started treatment within 6 months. Linkage to care was lowest among people who had tested previously and those aged 20-40 years. HBHTC was 50% cheaper (US11perpersontested,11 per person tested, 797 per individual enrolled in HIV care) than MHTC (24and24 and 1698, respectively). In this high HIV prevalence setting, a community-based testing programme achieved high uptake of testing, and appears to be an effective and affordable way to encourage large numbers of people to learn their HIV status (particularly underserved populations such as men and young people). However, for community HTC to impact mortality and incidence, strategies need to be implemented to ensure people testing HIV-positive in the community are linked to HIV care. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
Article
Full-text available
The outcome of HIV treatment has dramatically improved since the introduction of antiretroviral therapy. Studies confirm that if treatment of HIV is initiated when the immune system is not severely affected by the virus the prognosis for the outcome is significantly better. There is also evidence that many immigrants come late for their first HIV test. If found to be HIV positive, and if the immune system is already significantly affected, this will compromise the treatment outcome. This study was performed in an attempt to understand the barriers for early HIV testing in a migrant population from Ethiopia and Eritrea in Stockholm, Sweden. Participants were theoretically sampled and consisted of individuals who had immigrated from Ethiopia and Eritrea. Data were collected using 14 focus group discussions and seven semi-structured interviews. The analysis was performed according to a Grounded Theory approach using the paradigm model. Denial and fear of knowing one’s HIV status dominated all aspects of behavior in relation to HIV. The main strategy was a “fogging” of the issue of HIV. People were said to not want to know because this would bring social isolation and exclusion, and it was often believed that treatment did not help. This attitude had strong roots in their culture and past experiences that were brought along to the new country and maintained within the immigrant community. The length of time spent in Sweden seemed to be an important factor affecting the “fogging of the HIV issue”. In bridging the gap between the two cultures, Swedish authorities need to find ways to meet the needs of both earlier and newly arrived immigrants as well as the second generation of immigrants. This will require adjusting and updating the information that is given to these different sub-groups of Ethiopian and Eritrean immigrants. Appropriate access to healthcare for a diverse population obviously requires more than simply providing the healthcare services.
Article
Full-text available
As paediatric HIV treatment has become increasingly available across the world, the global perinatally infected cohort is ageing. However, we know surprisingly little about what it is like to grow up with HIV in resource-stretched settings. We draw on findings from a prospective, qualitative study with HIV-positive children, their carers and healthcare workers from four clinics in Uganda and Zimbabwe to examine children's experiences of living with HIV on treatment. We consider how the HIV experience is made in a symbiotic relationship between children, carers and healthcare workers and shaped by broader discourses. Despite the radical development in prognosis for children, their experience of HIV is largely constructed in relation to a language of 'sickness' through the promotion of medicalised talk and the recounting of past illness stories. This narrow narrative framework both reflects and reproduces core dimensions of the lived experience of growing up with HIV, which emphasises an absence of resilient healthiness in the face of ongoing vulnerability and risk. The challenges that children encounter in articulating alternative narratives that prioritise the relative buoyancy of their health is indicative of the broader uncertainty that exists around the future for these children at this point in the epidemic. © 2014 The Authors. Sociology of Health & Illness © 2014 Foundation for the Sociology of Health & Illness/John Wiley & Sons Ltd.
Article
Aim.The purpose of this paper is to outline understandings about the construction of sexuality and the impact of a changing body for women living with multiple sclerosis (MS). We suggest that the process of transition towards incorporating the experience of chronic illness into one's life is influenced by the (re)construction of self-identity. Design and methods.A participatory action process guided the research. The women joined the authors for five group sessions that totalled 15 hours of contact time. In addition, we offered women the opportunity for one-to-one interviews at home. Nine women volunteered to participate. This allowed us to gain additional in-depth data about individual experiences. The interpretive framework was guided by the self-identity literature. When reading the transcripts we questioned: What is going on here? What does this say about the construction of self? What does this say about the construction of identity? What influence does the body have in the construction of self-identity? Analysis was collaborative (with the women) and the resultant emerging construction of sexuality is shared in this paper. Data generated during one-to-one interviews are privileged and we include two accounts from women who live with MS. The women's stories focus on sexuality, however, within this sexual context, we observed shifts in self-identity which we contend may shape the illness transition experience. Findings.The rationale for privileging only two accounts is to expand understanding of Ordinariness and Extraordinariness with particular focus on the salience of the body in the ‘sexual’ lives of the women. Self-identity was shaped by how they felt about themselves as sexual beings, how they experienced their body, how they felt about sexual activities and by the way others reacted to them. Importantly, we view the women's sense of self, identity and the relationship to the body and find that shifts in self identity shape the woman's transition towards Ordinariness. Conclusions.This exploration of illness experiences is a reminder that our bodies are vehicles for our sense of self and identity. Cultural, educational, social, religious and family contexts all impact on women's capacity to shape the consequences of illness and the choices available to them. Facilitating women towards an awareness of the choices available in order to sustain or reclaim self may in turn expedite transition towards Ordinariness so that illness may become a part of their life.